Format
Sort by
Items per page

Send to

Choose Destination

Best matches for epstein-barr multiple sclerosis:

Search results

Items: 1 to 20 of 676

1.

Hypothesis: Multiple sclerosis is caused by three-hits, strictly in order, in genetically susceptible persons.

Kearns PKA, Casey HA, Leach JP.

Mult Scler Relat Disord. 2018 Jul 4;24:157-174. doi: 10.1016/j.msard.2018.06.014. [Epub ahead of print]

PMID:
30015080
2.

Infectious agents and different course of multiple sclerosis: a systematic review.

Saberi A, Akhondzadeh S, Kazemi S.

Acta Neurol Belg. 2018 Jul 13. doi: 10.1007/s13760-018-0976-y. [Epub ahead of print] Review.

PMID:
30006858
3.

Study of the possible link of 25-hydroxyvitamin D with Epstein-Barr virus and human herpesvirus 6 in patients with multiple sclerosis.

Pérez-Pérez S, Domínguez-Mozo MI, García-Martínez MÁ, Aladro Y, Martínez-Ginés M, García-Domínguez JM, López de Silanes C, Casanova I, Ortega-Madueño I, López-Lozano L, Torrejón MJ, Arroyo R, Álvarez-Lafuente R.

Eur J Neurol. 2018 Jul 11. doi: 10.1111/ene.13749. [Epub ahead of print]

PMID:
29996002
4.

A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study.

Gold J, Marta M, Meier UC, Christensen T, Miller D, Altmann D, Holden D, Bianchi L, Adiutori R, MacManus D, Yousry T, Schmierer K, Turner B, Giovannoni G.

Mult Scler Relat Disord. 2018 Jun 28;24:123-128. doi: 10.1016/j.msard.2018.06.002. [Epub ahead of print]

PMID:
29990894
5.

Vaccine Development for Epstein-Barr Virus.

Cohen JI.

Adv Exp Med Biol. 2018;1045:477-493. doi: 10.1007/978-981-10-7230-7_22.

PMID:
29896681
6.

Molecular signature of Epstein-Barr virus infection in MS brain lesions.

Moreno MA, Or-Geva N, Aftab BT, Khanna R, Croze E, Steinman L, Han MH.

Neurol Neuroimmunol Neuroinflamm. 2018 Jun 7;5(4):e466. doi: 10.1212/NXI.0000000000000466. eCollection 2018 Jul.

7.

The levels of soluble forms of CD21 and CD83 in multiple sclerosis.

Karampoor S, Zahednasab H, Etemadifar M, Keyvani H.

J Neuroimmunol. 2018 Jul 15;320:11-14. doi: 10.1016/j.jneuroim.2018.04.005. Epub 2018 Apr 13.

PMID:
29759135
8.

Lifestyle and Environmental Factors in Multiple Sclerosis.

Alfredsson L, Olsson T.

Cold Spring Harb Perspect Med. 2018 May 7. pii: a028944. doi: 10.1101/cshperspect.a028944. [Epub ahead of print]

PMID:
29735578
9.

EBI2 - Sensor for dihydroxycholesterol gradients in neuroinflammation.

Kurschus FC, Wanke F.

Biochimie. 2018 Apr 22. pii: S0300-9084(18)30101-9. doi: 10.1016/j.biochi.2018.04.014. [Epub ahead of print] Review.

PMID:
29689289
10.

Epstein-Barr virus-associated immune reconstitution inflammatory syndrome as possible cause of fulminant multiple sclerosis relapse after natalizumab interruption.

Serafini B, Zandee S, Rosicarelli B, Scorsi E, Veroni C, Larochelle C, D'Alfonso S, Prat A, Aloisi F.

J Neuroimmunol. 2018 Jun 15;319:9-12. doi: 10.1016/j.jneuroim.2018.03.011. Epub 2018 Mar 18. No abstract available.

PMID:
29685294
11.

Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity.

Harley JB, Chen X, Pujato M, Miller D, Maddox A, Forney C, Magnusen AF, Lynch A, Chetal K, Yukawa M, Barski A, Salomonis N, Kaufman KM, Kottyan LC, Weirauch MT.

Nat Genet. 2018 May;50(5):699-707. doi: 10.1038/s41588-018-0102-3. Epub 2018 Apr 16.

PMID:
29662164
12.

Recent developments in interferon-based therapies for multiple sclerosis.

Dumitrescu L, Constantinescu CS, Tanasescu R.

Expert Opin Biol Ther. 2018 Jun;18(6):665-680. doi: 10.1080/14712598.2018.1462793. Epub 2018 Apr 20.

PMID:
29624084
13.

HLA alleles modulate EBV viral load in multiple sclerosis.

Agostini S, Mancuso R, Guerini FR, D'Alfonso S, Agliardi C, Hernis A, Zanzottera M, Barizzone N, Leone MA, Caputo D, Rovaris M, Clerici M.

J Transl Med. 2018 Mar 27;16(1):80. doi: 10.1186/s12967-018-1450-6.

14.

Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls.

Leibovitch EC, Lin CM, Billioux BJ, Graves J, Waubant E, Jacobson S.

Mult Scler. 2018 Mar 1:1352458518765654. doi: 10.1177/1352458518765654. [Epub ahead of print]

PMID:
29569515
15.

Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the 'hygiene hypothesis'?

Alari-Pahissa E, Moreira A, Zabalza A, Alvarez-Lafuente R, Munteis E, Vera A, Arroyo R, Alvarez-Cermeño JC, Villar LM, López-Botet M, Martínez-Rodríguez JE.

Eur J Neurol. 2018 Jul;25(7):925-933. doi: 10.1111/ene.13622. Epub 2018 Apr 15.

PMID:
29528545
16.

Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder.

Bo M, Niegowska M, Arru G, Sechi E, Mariotto S, Mancinelli C, Farinazzo A, Alberti D, Gajofatto A, Ferrari S, Capra R, Monaco S, Sechi G, Sechi LA.

J Neuroimmunol. 2018 May 15;318:97-102. doi: 10.1016/j.jneuroim.2018.02.013. Epub 2018 Feb 28.

PMID:
29519720
17.

Could antiretrovirals be treating EBV in MS? A case report.

Drosu NC, Edelman ER, Housman DE.

Mult Scler Relat Disord. 2018 May;22:19-21. doi: 10.1016/j.msard.2018.02.029. Epub 2018 Feb 27.

18.

Humoral response to John Cunningham virus during pregnancy in multiple sclerosis.

Saraste M, Atula S, Hedman K, Hurme S, Jalkanen A, Sneck M, Surcel HM, Maghzi AH, Airas L.

Mult Scler Relat Disord. 2018 Apr;21:11-18. doi: 10.1016/j.msard.2018.02.008. Epub 2018 Feb 9.

19.

Seroepidemiological Study of Epstein-Barr Virus in Different Population Groups in Croatia.

Beader N, Kolarić B, Slačanac D, Tabain I, Vilibić-Čavlek T.

Isr Med Assoc J. 2018 Feb;20(2):86-90.

20.

Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells.

Hassani A, Corboy JR, Al-Salam S, Khan G.

PLoS One. 2018 Feb 2;13(2):e0192109. doi: 10.1371/journal.pone.0192109. eCollection 2018.

Supplemental Content

Loading ...
Support Center